Gateway Blog

Gateway Blog

Immunotherapy Momentum Grows, Patient With Metastatic Breast Cancer Disease-Free

By Admin at 23 Oct 2017

At a meeting of the American Association of Cancer Research in Boston, Dr. Steven Rosenberg, researcher and chief of surgery at the National Cancer Institute (NCI) reported on the first patient with metastatic breast cancer to be essentially cured following immunotherapy treatment.

0 comments posted

Can Cancer Interception Stop Cancer From Forming?

By Admin at 30 Mar 2017

Part of the challenge of winning the war against cancer lies in treating the disease in its later stages — a point at which many cancers become hard, if not impossible, to eliminate. Cancer interception may change that by targeting cancer at its earliest stages, in some cases even before it starts.

0 comments posted

Gateway Funded Immune Therapy Study Opens Doors in the Fight Against Brain Cancer

By Admin at 12 Jan 2017

A Gateway-funded clinical trial is making big news for breakthrough success in brain cancer. For the first time, researchers have successfully used a form of immunotherapy, which harnesses a patient’s own immune system to fight cancer, to treat an aggressive type of brain tumor called glioblastoma.

0 comments posted

‘More and More’ Immunotherapy Treatments Are Being Approved, Positively Impacting Cancer

By Admin at 22 Aug 2016

Certain types of immunotherapy drugs have been making significant impacts on cancer treatments since 2011, and five years later they are still a large force in making aggressive and hard-to-treat cancers beatable.

0 comments posted

Immunotherapy Could Raise Survival Rates for Ovarian Cancer

By Admin at 13 Jul 2016

A new study showed that incorporating immunotherapy into ovarian cancer treatment might combat chemotherapy resistance and improve survival rates.

0 comments posted

    Categories

    Archive

    2018 2017 2016 2015
    99 cents of every dollar received directly funds cancer clinical trials

    58

    Current Gateway-funded clinical trials

    150+

    Clinical trials funded at leading institutions worldwide

    $16.56

    Funds one patient for one day at a Gateway-funded clinical trial

     
     

    Mission Partners